These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26818866)

  • 1. Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of Protein-Protein Interactions in Current and Future Treatment.
    Thomsen MS; Andreasen JT; Arvaniti M; Kohlmeier KA
    Curr Pharm Des; 2016; 22(14):2015-34. PubMed ID: 26818866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
    Ni R; Marutle A; Nordberg A
    J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The wonderland of neuronal nicotinic acetylcholine receptors.
    Bertrand D; Terry AV
    Biochem Pharmacol; 2018 May; 151():214-225. PubMed ID: 29248596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S; Kumar A; Tripathi T; Kumar A
    J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease.
    Jensen MM; Arvaniti M; Mikkelsen JD; Michalski D; Pinborg LH; Härtig W; Thomsen MS
    Neurobiol Aging; 2015 Apr; 36(4):1629-1638. PubMed ID: 25680266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications.
    Nordberg A
    Biol Psychiatry; 2001 Feb; 49(3):200-10. PubMed ID: 11230871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.
    Thomsen MS; Hansen HH; Timmerman DB; Mikkelsen JD
    Curr Pharm Des; 2010 Jan; 16(3):323-43. PubMed ID: 20109142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR; Hernandez CM; Dineley KT
    Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases.
    Fuenzalida M; Pérez MÁ; Arias HR
    Curr Pharm Des; 2016; 22(14):2004-14. PubMed ID: 26818867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations.
    Stoiljkovic M; Kelley C; Nagy D; Leventhal L; Hajós M
    Neuropharmacology; 2016 Nov; 110(Pt A):102-108. PubMed ID: 27422408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New nicotinic analogue ZY-1 enhances cognitive functions in a transgenic mice model of Alzheimer's disease.
    Nie H; Wang Z; Zhao W; Lu J; Zhang C; Lok K; Wang Y; Shen H; Xu Z; Yin M
    Neurosci Lett; 2013 Mar; 537():29-34. PubMed ID: 23340201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease.
    Small DH; Fodero LR
    J Alzheimers Dis; 2002 Oct; 4(5):349-55. PubMed ID: 12446967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia.
    Woodruff-Pak DS; Gould TJ
    Behav Cogn Neurosci Rev; 2002 Mar; 1(1):5-20. PubMed ID: 17715584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.